Q301--VISN 17 Oncotype DX Prostate Testing Consolidation BPA

The Department of Veterans Affairs (VA) intends to issue a sole source award to MDXHealth, Inc. for the provision of gene expression assay and Oncotype DX testing for cancers of the prostate. The contractor must provide these services for the Pathology & Laboratory Medicine Service (P&LMS) for several VA healthcare systems in Texas. The contractor's laboratory must provide Oncotype DX genomic oncology testing and have all necessary licenses, permits, and accreditation certificates. Key requirements include: • Providing gene expression assay and Oncotype DX testing for cancers of the prostate • Having a laboratory that can provide Oncotype DX genomic oncology testing • Having all necessary licenses, permits, and accreditation certificates • Registering in the System for Award Management (SAM) database • Being listed as verified on the Veteran Small Business Certification (VetCert) database for Service Disabled Veteran Owned Small Businesses (SDVOSB) and Veteran Owned Small Businesses (VOSB)